New Japan Partner For Solasia’s Key Oncology Project
This article was originally published in PharmAsia News
Executive Summary
The Japanese venture Solasia has signed a product licensing and investment agreement with major firm Meiji Seika that will support the planned commercialization of its major oncology prospect.